SomnoMed Limited (ASX:SOM)
0.5350
+0.0050 (0.94%)
Jun 26, 2026, 3:55 PM AEST
SomnoMed Market Cap
SomnoMed has a market cap or net worth of 117.21 million as of June 26, 2026. Its market cap has increased by 4.30% in one year.
Market Cap
117.21M
Enterprise Value
105.79M
Revenue
118.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.54
Market Cap Chart
Since August 27, 2004, SomnoMed's market cap has increased from 35.20M to 117.21M, an increase of 232.95%. That is a compound annual growth rate of 5.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 117.21M | -30.46% |
| Dec 30, 2025 | 168.55M | 69.55% |
| Dec 27, 2024 | 99.41M | 83.09% |
| Dec 29, 2023 | 54.30M | -49.14% |
| Dec 28, 2022 | 106.76M | -45.11% |
| Dec 31, 2021 | 194.48M | 11.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EBR Systems | 236.24M |
| Aroa Biosurgery | 204.08M |
| EMVision Medical Devices | 140.83M |
| Lumos Diagnostics Holdings | 106.25M |
| Saluda Medical | 100.81M |
| Epiminder | 69.23M |
| Cleo Diagnostics | 65.01M |
| Compumedics | 47.94M |